文献速递肝病消化道肿瘤与早癌

缺氧诱导的髓系细胞触发受体-1阳性肿瘤相关巨噬细胞阻断可逆转肝癌免疫抑制及抗程序性死亡配体1耐药

Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
PubMed 文献 · Hepatology · 2019-04-12

研究探讨缺氧环境下肝癌中TREM-1阳性肿瘤相关巨噬细胞的行为及其在免疫抑制和抗PD-L1耐药中的作用。缺氧诱导因子1α诱导TAMs中TREM-1表达增加,TREM-1阳性TAMs通过CCR6+ Foxp3+ Treg招募介导免疫抑制和抗PD-L1耐药,阻断TREM-1通路可抑制肿瘤进展并提高PD-L1阻断疗效。

要点

  • 缺氧诱导因子1α诱导TAMs中TREM-1表达增加,导致免疫抑制。
  • TREM-1阳性TAMs通过CCR6+ Foxp3+ Treg招募介导肝癌抗PD-L1耐药。
  • 阻断TREM-1通路可抑制肿瘤进展并改善PD-L1阻断疗效。

核心结论

  • 缺氧环境通过TREM-1阳性TAMs招募CCR6+ Foxp3+ Tregs启动肿瘤免疫抑制,TREM-1阳性TAMs赋予肝癌抗PD-L1治疗耐药。

研究设计与样本

  • 研究采用生物学和功能学检测,并在体内评估TREM-1阳性TAMs对自发和PD-L1阻断介导的抗肿瘤效应的影响。

主要发现

  • 缺氧诱导因子1α诱导TAMs中TREM-1表达增加,TREM-1阳性TAMs在晚期肝癌进展中丰富,间接损害CD8+ T细胞毒性功能并诱导CD8+ T细胞凋亡。
  • 生物学和功能学检测显示,缺氧环境下TREM-1阳性TAMs的PD-L1表达更高。
  • TREM-1阳性TAMs可在体内消除自发和PD-L1阻断介导的抗肿瘤效应,提示其免疫抑制依赖独立于PD-L1/PD-1轴的途径。
  • TREM-1阳性TAMs通过细胞外信号调节激酶/NF-κβ通路提升CCL20表达,导致CCR6+ Foxp3+ Treg积累。
  • 阻断TREM-1通路可显著抑制肿瘤进展、减少CCR6+ Foxp3+ Treg招募并改善PD-L1阻断的疗效。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tumor-associated macrophages (TAMs) are recognized as antitumor suppressors, but how TAMs behave in the hypoxic environment of hepatocellular carcinoma (HCC) remains unclear. Here, we demonstrated that hypoxia inducible factor 1α induced increased expression of triggering receptor expressed on myeloid cells-1 (TREM-1) in TAMs, resulting in immunosuppression. Specifically, TREM-1-positive (TREM-1+ ) TAMs abundant at advanced stages of HCC progression indirectly impaired the cytotoxic functions of CD8+ T cells and induced CD8+ T-cells apoptosis. Biological and functional assays showed that TREM-1+ TAMs had higher expression of programmed cell death ligand 1 (PD-L1) under hypoxic environment. However, TREM-1+ TAMs could abrogate spontaneous and PD-L1-blockade-mediated antitumor effects in vivo, suggesting that TREM-1+ TAM-induced immunosuppression was dependent on a pathway separate from PD-L1/programmed cell death 1 axis. Moreover, TREM-1+ TAM-associated regulatory T cells (Tregs) were crucial for HCC resistance to anti-PD-L1 therapy. Mechanistically, TREM-1+ TAMs elevated chemokine (C-C motif) ligand 20 expression through the extracellular signal-regulated kinase/NF-κβ pathway in response to hypoxia and tumor metabolites leading to CCR6+ Foxp3+ Treg accumulation. Blocking the TREM-1 pathway could significantly inhibit tumor progression, reduce CCR6+ Foxp3+ Treg recruitment, and improve the therapeutic efficacy of PD-L1 blockade. Thus, these data demonstrated that CCR6+ Foxp3+ Treg recruitment was crucial for TREM-1+ TAM-mediated anti-PD-L1 resistance and immunosuppression in hypoxic tumor environment. Conclusion: This study highlighted that the hypoxic environment initiated the onset of tumor immunosuppression through TREM-1+ TAMs attracting CCR6+ Foxp3+ Tregs, and TREM-1+ TAMs endowed HCC with anti-PD-L1 therapy resistance.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Wu Q, Zhou W, Yin S, et al. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer. Hepatology. 2019. PMID: 30810243. doi:10.1002/hep.30593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。